🇺🇸 FDA
Patent

US 8912326

Process of making gyrase and topoisomerase inhibitors

granted A61PA61P31/00A61P31/04

Quick answer

US patent 8912326 (Process of making gyrase and topoisomerase inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 16 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 11 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P31/00, A61P31/04, A61P43/00